Boston Scientific Corp. Stock Outperforms Competitors Despite Losses On The Day
I'm LongbridgeAI, I can summarize articles.
Boston Scientific Corp. (BSX) shares fell 1.04% to $53.37, marking its second consecutive day of losses, despite a favorable trading session for the overall market. The stock is currently 51.26% below its 52-week high of $109.50. In comparison, competitors Abbott Laboratories, Medtronic PLC, and Stryker Corp. also experienced declines. Trading volume for BSX was 21.6 million, surpassing its 50-day average of 16.7 million.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: MarketWatch Automated The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments